Using high-throughput genomics to study hepatitis C: What determines the outcome of infection?
- 31 March 2009
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 81 (3), 198-208
- https://doi.org/10.1016/j.antiviral.2008.12.005
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesisHepatology, 2008
- Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment responseHepatology, 2007
- Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virusHepatology, 2007
- Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virusNature, 2006
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- VISA Is an Adapter Protein Required for Virus-Triggered IFN-β SignalingMolecular Cell, 2005
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005
- IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon inductionNature Immunology, 2005
- Evasion of intracellular host defence by hepatitis C virusNature, 2005
- Host factors and failure of interferon-α treatment in hepatitis C virusHepatology, 2004